Radiation Therapy in Gynecologic Malignancies Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Radiation Therapy in Gynecologic Malignancies. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Radiation Therapy in Gynecologic Malignancies Indian Medical PG Question 1: Radiation mediates its effect by
- A. Protein coagulation
- B. Osmolysis of cells
- C. Ionization of the molecules (Correct Answer)
- D. Denaturation of DNA
Radiation Therapy in Gynecologic Malignancies Explanation: ***Ionization of the molecules***
- Radiation, particularly **ionizing radiation**, interacts with biological molecules by ejecting electrons, leading to the formation of highly reactive **ions and free radicals** [1].
- This **ionization** process is the primary mechanism by which radiation damages cellular components, including **DNA** [2].
*Protein coagulation*
- While radiation can cause protein damage, **coagulation** is not its primary or direct mechanism, especially at clinically relevant doses.
- Protein coagulation is more typically associated with **heat** or certain strong chemical agents.
*Osmolysis of cells*
- **Osmolysis** refers to the rupture of cells due to excessive water influx, often caused by changes in osmotic pressure.
- Radiation does not directly induce **osmotic imbalances** leading to cell lysis.
*Denaturation of DNA*
- While radiation ultimately leads to **DNA damage**, denaturation (unfolding) is a specific type of damage, often caused by heat or extreme pH.
- The direct effect of radiation is **ionization**, which then indirectly causes various forms of DNA damage including breaks, cross-links, and base modifications, but not solely "denaturation" [1].
**References:**
[1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 101-102.
[2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Central Nervous System Synapse, pp. 436-437.
Radiation Therapy in Gynecologic Malignancies Indian Medical PG Question 2: A child undergoes prophylactic irradiation as preparation for bone marrow transplantation (BMT) for treatment of acute lymphoblastic leukemia (ALL). Which of the following cell types will be least affected by the radiation?
- A. Spermatogonia
- B. Bone marrow
- C. Intestinal epithelial cells
- D. Neurons (Correct Answer)
Radiation Therapy in Gynecologic Malignancies Explanation: ***Neurons***
- **Neurons** are highly differentiated cells with very low rates of cell division in adults. As radiation primarily targets rapidly dividing cells [4], **neurons are least susceptible** to radiation damage.
- While high doses of radiation can eventually damage neurons, their **radioresistance** is significantly higher compared to rapidly proliferating tissues.
*Spermatogonia*
- **Spermatogonia** are germ cells that undergo continuous and rapid division to produce sperm, making them **highly sensitive to radiation** [2].
- Radiation exposure can lead to **sterility** due to the destruction of these rapidly dividing cells [2].
*Bone marrow*
- The **bone marrow** contains hematopoietic stem cells that are responsible for the continuous production of blood cells, involving **rapid cell division** [3].
- It is one of the most **radiosensitive tissues** [1], and radiation exposure can lead to **myelosuppression** and pancytopenia.
*Intestinal epithelial cells*
- **Intestinal epithelial cells** have a high turnover rate due to their constant shedding and replacement [5], making them **very sensitive to radiation** [1].
- Radiation damage to these cells can cause **mucositis, nausea, vomiting, and diarrhea**.
**References:**
[1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 112-113.
[2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 113-114.
[3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 112-113.
[4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Central Nervous System Synapse, pp. 436-437.
[5] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 79-80.
Radiation Therapy in Gynecologic Malignancies Indian Medical PG Question 3: Use of OCPs is known to protect against the following malignancies except:
- A. Colorectal carcinomas
- B. Carcinoma cervix (Correct Answer)
- C. Ovarian carcinoma
- D. Endometrial carcinoma
Radiation Therapy in Gynecologic Malignancies Explanation: ***Carcinoma cervix***
- While oral contraceptive pills (OCPs) offer protection against some cancers, they are **not protective against cervical cancer**.
- In fact, long-term use of OCPs is considered a **risk factor for cervical cancer**, especially in conjunction with human papillomavirus (HPV) infection.
*Colorectal carcinomas*
- OCP use has been consistently associated with a **reduced risk of colorectal cancer**.
- The protective effect is thought to be mediated by various hormonal mechanisms, including their impact on **bile acid metabolism** and **estrogen receptors in the colon**.
*Ovarian carcinoma*
- OCPs provide significant and **long-lasting protection against ovarian cancer**.
- This protective effect is believed to be due to the **suppression of ovulation**, thereby reducing the continuous trauma and repair of the ovarian epithelium.
*Endometrial carcinoma*
- OCPs are known to offer substantial **protection against endometrial cancer**.
- The progestin component in combined OCPs effectively **counteracts the proliferative effects of estrogen** on the endometrium, reducing the risk of hyperplasia and subsequent cancer.
Radiation Therapy in Gynecologic Malignancies Indian Medical PG Question 4: In which stage of cervical cancer is brachytherapy primarily utilized?
- A. Stage IVB cervical cancer
- B. Stage II-III cervical cancer (Correct Answer)
- C. Stage IA cervical cancer
- D. Stage Ib1 cervical cancer
Radiation Therapy in Gynecologic Malignancies Explanation: ***Stage II-III cervical cancer***
- **Brachytherapy** is a crucial component of definitive chemoradiation in locally advanced cervical cancer, targeting the uterus and cervix.
- This stage often involves **regional spread** to parametrial tissues or lower vagina, requiring combined external beam radiation therapy (EBRT) and brachytherapy for optimal local control.
- **Chemoradiation with brachytherapy is the PRIMARY treatment modality** for Stage II-III, making this the stage where brachytherapy is most prominently utilized.
*Stage IVB cervical cancer*
- This stage involves **distant metastases**, where the primary treatment strategy shifts towards **palliative systemic therapy** (chemotherapy or immunotherapy).
- While localized radiation might be used for symptom control, **brachytherapy** alone is not curative and not the primary treatment modality.
*Stage IA cervical cancer*
- This stage represents very **early-stage disease** confined to the cervix, typically treated with **surgical excision** (e.g., cone biopsy or hysterectomy).
- Radiotherapy, including brachytherapy, is generally reserved for patients who are not surgical candidates or for those with high-risk features post-surgery.
*Stage Ib1 cervical cancer*
- This stage involves a **tumor confined to the cervix** (visible lesion ≤2 cm), with **two equal treatment options**: **radical hysterectomy** OR **definitive chemoradiation** with brachytherapy.
- While brachytherapy is used when radiation is chosen for Ib1, it serves as an ALTERNATIVE to surgery rather than the PRIMARY modality, unlike in Stage II-III where radiation is the standard first-line treatment.
Radiation Therapy in Gynecologic Malignancies Indian Medical PG Question 5: Which is used in both teletherapy and brachytherapy?
- A. Iodine 131
- B. Cobalt 60 (Correct Answer)
- C. Iridium 192
- D. Palladium
Radiation Therapy in Gynecologic Malignancies Explanation: ***Cobalt 60***
- **Cobalt-60** is the correct answer as it is used in both **teletherapy and brachytherapy**.
- **Teletherapy**: Cobalt-60 teletherapy machines (cobalt units) have been widely used for external beam radiation therapy and remain in use globally.
- **Brachytherapy**: Cobalt-60 is used in both low-dose rate (LDR) and high-dose rate (HDR) brachytherapy applications, with Co-60 seeds and sources for various tumor sites.
- Its high energy (1.17 and 1.33 MeV gamma rays) and suitable half-life (5.27 years) make it versatile for both modalities.
*Iridium 192*
- **Iridium-192** is predominantly used in **HDR brachytherapy** as a temporary implant source.
- It is the most common radioisotope for modern HDR brachytherapy systems.
- While it emits gamma radiation, it is **not routinely used for teletherapy** in clinical practice due to its lower energy and shorter half-life (74 days).
*Palladium*
- **Palladium-103** is used exclusively in **low-dose rate (LDR) brachytherapy**, particularly for permanent seed implants in prostate cancer.
- Its lower energy photons and short half-life (17 days) make it unsuitable for teletherapy.
*Iodine 131*
- **Iodine-131** is primarily used in **nuclear medicine** for thyroid cancer treatment and hyperthyroidism (targeted radionuclide therapy).
- It is not used for conventional external beam teletherapy or brachytherapy implants.
Radiation Therapy in Gynecologic Malignancies Indian Medical PG Question 6: Most common acute skin manifestation of radiotherapy:
- A. Dermatitis
- B. Erythema (Correct Answer)
- C. Atopy
- D. Hyperpigmentation
Radiation Therapy in Gynecologic Malignancies Explanation: ***Erythema***
- **Erythema** (redness) is the most immediate and common acute cutaneous reaction to radiotherapy due to **vasodilation** and inflammation of the skin in the irradiated area.
- It often appears within days to weeks of starting radiation treatment and is a direct consequence of cell damage and the body's inflammatory response to it.
*Dermatitis*
- While radiation dermatitis is a broader term encompassing various skin changes from radiotherapy, **erythema** is the initial and most prevalent component of this dermatological spectrum, making it a more specific answer for the "most common" manifestation.
- Dermatitis can also include later-stage problems like **dry desquamation** and **moist desquamation**, which are more severe reactions.
*Atopy*
- **Atopy** refers to a genetic predisposition to develop allergic diseases like asthma, allergic rhinitis, or atopic dermatitis.
- It is an **intrinsic immune predisposition** and not a direct skin manifestation caused by radiotherapy itself.
*Hyperpigmentation*
- While **hyperpigmentation** can occur in the irradiated area, it is typically a **subacute or chronic** reaction, often appearing weeks to months after the onset of erythema or after the completion of treatment.
- It is not the most immediate or common acute manifestation compared to erythema.
Radiation Therapy in Gynecologic Malignancies Indian Medical PG Question 7: Which of the following is NOT an indication for postoperative radiotherapy in a case of carcinoma endometrium?
- A. Positive lymph nodes
- B. Endocervical involvement
- C. Myometrial invasion >1/2 thickness
- D. Tumor positive for estrogen receptors (Correct Answer)
Radiation Therapy in Gynecologic Malignancies Explanation: ***Tumor positive for estrogen receptors***
- A tumor being **positive for estrogen receptors** indicates a potential responsiveness to **hormonal therapy**, rather than an indication for postoperative radiotherapy.
- While it guides treatment decisions, it does not suggest a need for radiation to reduce local recurrence risk, unlike other high-risk features.
*Myometrial invasion >1/2 thickness*
- **Deep myometrial invasion (>1/2 thickness)** is a significant **risk factor for recurrence** and metastases in endometrial carcinoma.
- Radiotherapy is often indicated in such cases to improve **local control** and reduce recurrence.
*Positive lymph nodes*
- The presence of **positive lymph nodes** signifies regional spread of the cancer.
- This is a strong indication for **adjuvant therapy**, including radiotherapy, to target residual disease and prevent recurrence.
*Endocervical involvement*
- **Endocervical stromal invasion** indicates a more aggressive tumor that has extended beyond the endometrium.
- This finding is associated with a higher risk of **locoregional recurrence**, making postoperative radiotherapy a crucial component of treatment to improve outcomes.
Radiation Therapy in Gynecologic Malignancies Indian Medical PG Question 8: Which of the following statements about radical hysterectomy in stage Ib cervical cancer compared to radiotherapy is false?
- A. Chance of recurrence is lower with radical hysterectomy.
- B. Ovarian function can be preserved.
- C. Chance of survival is higher with radical hysterectomy.
- D. It is less complicated than radiotherapy. (Correct Answer)
Radiation Therapy in Gynecologic Malignancies Explanation: ***It is less complicated than radiotherapy.***
- Radical hysterectomy is a **major surgical procedure** with potential complications like **hemorrhage**, infection, **ureteral injury**, and **lymphedema**, which can be significant and life-altering.
- Radiotherapy, while having its own set of side effects (e.g., **vaginal stenosis**, bladder/rectal irritation), typically avoids the acute surgical risks and recovery period associated with extensive surgery.
*Chance of recurrence is lower with radical hysterectomy.*
- For early-stage cervical cancer (Ib1/Ib2), both **radical hysterectomy** and **radiotherapy** provide **comparable outcomes** in terms of recurrence rates.
- The choice between therapies often depends on patient factors, surgeon expertise, and pathological findings, but neither consistently demonstrates a significantly lower recurrence rate over the other in large cohorts.
*Ovarian function can be preserved.*
- In younger patients undergoing **radical hysterectomy**, it is often possible to **preserve the ovaries** by transplanting them or avoiding their removal if not directly involved, thus maintaining **endocrine function**.
- **Pelvic radiotherapy**, in contrast, invariably leads to **ovarian radiation** and subsequent **ovarian failure** and menopause.
*Chance of survival is higher with radical hysterectomy.*
- For early-stage cervical cancer (Ib), **overall survival rates** are generally **equivalent** between radical hysterectomy and primary radiotherapy.
- Meta-analyses and large retrospective studies have shown **similar 5-year survival rates** for both treatment modalities when applied appropriately to well-selected patients.
Radiation Therapy in Gynecologic Malignancies Indian Medical PG Question 9: In which of the following cancers is intraoperative radiotherapy (IORT) applicable?
- A. Gastric cancer
- B. Colon carcinoma
- C. Pancreatic carcinoma
- D. All of the options (Correct Answer)
Radiation Therapy in Gynecologic Malignancies Explanation: ***All of the options***
- **Intraoperative radiotherapy (IORT)** is applicable to all three cancers listed: gastric cancer, colon carcinoma, and pancreatic carcinoma.
- IORT is a technique where a **single, high dose of radiation** is delivered to the tumor bed during surgery to improve local control and reduce late toxicity to surrounding healthy tissues.
- All three cancers benefit from IORT due to their **high risk of local recurrence** and the ability to directly target the tumor bed while sparing adjacent critical organs.
**Gastric cancer:**
- IORT addresses **high rates of local recurrence** after conventional surgery, especially in locally advanced stages
- Allows direct radiation of potentially involved regional lymph nodes or margins difficult to eradicate surgically
- Particularly useful when complete surgical clearance carries excessive morbidity risk
**Colon carcinoma:**
- IORT considered in **locally advanced or recurrent disease**, particularly when tumors invade adjacent structures
- Beneficial after resections with positive or close margins
- Delivers high dose to microscopic residual disease in the tumor bed, avoiding damage to vital organs from external beam radiotherapy
**Pancreatic carcinoma:**
- High propensity for **local invasion and recurrence** makes IORT particularly relevant
- Delivers high dose directly to tumor bed following resection when microscopic residual disease is suspected
- Overcomes limitations of external beam radiation due to proximity of critical organs (duodenum, stomach, kidneys)
Radiation Therapy in Gynecologic Malignancies Indian Medical PG Question 10: Which of the following is/are most radioresistant?
- A. Neurons
- B. Muscle cells
- C. Erythrocytes (Correct Answer)
- D. All of the options
Radiation Therapy in Gynecologic Malignancies Explanation: ***Erythrocytes***
- Erythrocytes are **anucleated** and terminally differentiated cells, meaning they do not divide. Cells that do not divide are generally **radioresistant**.
- Their primary function is oxygen transport, and they have a limited metabolic capacity, making them less susceptible to the genetic damage that typically leads to radiation-induced cell death.
*Neurons*
- While neurons are **post-mitotic** and generally radioresistant compared to rapidly dividing cells, they are still more susceptible than mature erythrocytes.
- High doses of radiation can lead to neuronal damage and death through mechanisms like **apoptosis** and indirect effects from damage to surrounding glial cells and vasculature.
*Muscle cells*
- Muscle cells (myocytes) are **terminally differentiated** and have a low mitotic rate, making them relatively radioresistant.
- However, they are still more sensitive to radiation than erythrocytes, and high doses can cause muscle degeneration and fibrosis.
*All of the options*
- This option is incorrect because while neurons and muscle cells are relatively radioresistant, **erythrocytes are demonstrably the most radioresistant** among the choices due to their complete lack of a nucleus and inability to divide.
More Radiation Therapy in Gynecologic Malignancies Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
